Cambrex, Merrimack deal

CBM’s Cambrex Bio Sciences Hopkinton Inc. subsidiary (Hopkinton, Mass.) will produce clinical trial batches of Merrimack’s MM-093 recombinant human alpha-fetoprotein. The compound is in Phase II test...